Giulia Prono is a master student in Molecular Biotechnology at the University of Turin (Italy). In 2020, she received her Bachelor's degree in Biotechnology at the University of Turin (Italy). During her undergraduate study, she has done research experience as an intern at the Molecular Biotechnology Center (MBC) of Turin, where she focused on the in vitro and in vivo assessment of drug therapies for cystic fibrosis (CF). She is currently doing an internship in the same field at MBC to further expand her knowledge of the molecular and biological aspects of CF and define her Master's thesis work.